HBMBF (HBM Healthcare Investments) Beneish M-Score: 9.11 (As of Jun. 26, 2026) — 353% Above Median


HBMBF HBM Healthcare Investments Ltd HBMBF
24 GF Score
Price $287.35
! 6 Warning Signs
View Full Analysis

What is HBM Healthcare Investments Beneish M-Score?

HBM Healthcare Investments HBMBF 24 Beneish M-Score is 9.11 as of Jun. 26, 2026, which is 353% above its 10-year median of 2.01. GuruFocus rates HBMBF with a GF Score™ of 24/100. The stock has 6 warning signs investors should review. Among 954 Asset Management companies, HBM Healthcare Investments ranks worse than 95.07% on this metric.

Note: Financial institutions were excluded from the sample in Beneish paper when calculating Beneish M-Score. Thus, the prediction might not fit banks and insurance companies.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 9.11 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for HBM Healthcare Investments's Beneish M-Score or its related term are showing as below:

HBMBF' s Beneish M-Score Range Over the Past 10 Years
Min: -3.21   Med: 2.01   Max: 10.45
Current: 9.11

During the past 13 years, the highest Beneish M-Score of HBM Healthcare Investments was 10.45. The lowest was -3.21. And the median was 2.01.

HBMBF
24GF Score
HBM Healthcare Investments Ltd HBMBF
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HBM Healthcare Investments Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of HBM Healthcare Investments for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1+0.528 * 1+0.404 * 1+0.892 * 15.1803+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.0761+4.679 * 0.140777-0.327 * 0.8996
=11.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $0.0 Mil.
Revenue was -17.657 + 240.216 + 296.885 + -171.482 = $348.0 Mil.
Gross Profit was -17.657 + 240.216 + 296.885 + -171.482 = $348.0 Mil.
Total Current Assets was $0.0 Mil.
Total Assets was $2,472.8 Mil.
Property, Plant and Equipment(Net PPE) was $0.0 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.0 Mil.
Selling, General, & Admin. Expense(SGA) was $2.8 Mil.
Total Current Liabilities was $0.0 Mil.
Long-Term Debt & Capital Lease Obligation was $126.7 Mil.
Net Income was -18.509 + 239.494 + 295.973 + -172.223 = $344.7 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = $0.0 Mil.
Cash Flow from Operations was -0.442 + -0.463 + -0.986 + -1.482 = $-3.4 Mil.
 Total Receivables was $0.0 Mil.
Revenue was -53.569 + 49.881 + -2.607 + 29.217 = $22.9 Mil.
Gross Profit was -53.569 + 49.881 + -2.607 + 29.217 = $22.9 Mil.
Total Current Assets was $0.0 Mil.
Total Assets was $1,978.4 Mil.
Property, Plant and Equipment(Net PPE) was $0.0 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.0 Mil.
Selling, General, & Admin. Expense(SGA) was $2.4 Mil.
Total Current Liabilities was $0.0 Mil.
Long-Term Debt & Capital Lease Obligation was $112.7 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0 / 347.962) / (0 / 22.922)
=0 / 0
=1

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(22.922 / 22.922) / (347.962 / 347.962)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (0 + 0) / 2472.755) / (1 - (0 + 0) / 1978.405)
=1 / 1
=1

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=347.962 / 22.922
=15.1803

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 0)) / (0 / (0 + 0))
= /
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2.797 / 347.962) / (2.421 / 22.922)
=0.008038 / 0.105619
=0.0761

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((126.709 + 0) / 2472.755) / ((112.689 + 0) / 1978.405)
=0.051242 / 0.05696
=0.8996

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(344.735 - 0 - -3.373) / 2472.755
=0.140777

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

HBM Healthcare Investments has a M-score of 11.02 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 9.11 mean?
HBM Healthcare Investments (HBMBF) has a Beneish M-Score of 9.11 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on HBM Healthcare Investments and its competitors. This is 353% above median its historical median of 2.01. According to the industry distribution chart, HBM Healthcare Investments ranks #907 out of 954 companies in the Asset Management industry, placing it in the top 95.1%.
Is HBM Healthcare Investments' Beneish M-Score too high?
HBM Healthcare Investments' current Beneish M-Score of 9.11 is 353% above median its 10-year median of 2.01. Based on the distribution chart, HBM Healthcare Investments ranks #907 out of 954 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, HBM Healthcare Investments has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does HBM Healthcare Investments' Beneish M-Score compare to BLK and BX?
According to the Asset Management industry distribution chart, HBM Healthcare Investments ranks #907 out of 954 companies for Beneish M-Score. This places HBM Healthcare Investments in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for an Asset Management company?
A good Beneish M-Score depends on the Asset Management industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on HBM Healthcare Investments and its competitors. HBM Healthcare Investments's current Beneish M-Score is 9.11, which is 353% above median its own 10-year median of 2.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HBM Healthcare Investments stock overvalued right now?
HBM Healthcare Investments (HBMBF) has a current Beneish M-Score of 9.11. The current Beneish M-Score is 9.11, which is 353% above median its 10-year median of 2.01. HBM Healthcare Investments' overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For HBM Healthcare Investments (HBMBF), the current Beneish M-Score is 9.11 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HBM Healthcare Investments Business Description

Address Bundesplatz 1, Zug, CHE, 6300
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of companies.
24GF Score

Get the complete analysis for HBMBF

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$287.35
Price